BZETH
Live / Allowed — Published for opposition (as of 15 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 10 Sept 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99385865
- Mark type
- Stylized text
- Filed
- 10 Sept 2025
- Published for opposition
- 15 Sept 2026
- Attorney of record
- Stephen A. Seach, Jr.
Goods and services
- Class 005 — Pharmaceuticals: House mark for a full line of prescription and over-the-counter pharmaceutical preparations for humans for the treatment and management of enzyme-deficiency disorders, digestive insufficiency, and chronic diseases addressed through biologic or biosimilar therapies, namely, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, and endocrine diseases and disorders
Owner
- BioZen Therapeutics Inc., Monroe, NJ, US
- BioZen Therapeutics Inc., Monroe, NJ, US
Prosecution history
- 15 Sept 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Sept 2026 — PUBLISHED FOR OPPOSITION
- 09 Sept 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 Aug 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Aug 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 13 Aug 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 13 Aug 2026 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 14 Jul 2026 — NOTIFICATION OF SUBSEQUENT FINAL EMAILED
- 14 Jul 2026 — CONTINUATION OF FINAL REFUSAL E-MAILED
- 14 Jul 2026 — ACTION CONTINUING A FINAL - COMPLETED
- 19 Jun 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 19 Jun 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 19 Jun 2026 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 19 Mar 2026 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 19 Mar 2026 — FINAL REFUSAL E-MAILED